Nicaise Claude bought SRPT
March 12, 2025 · Form 4 insider transaction
Nicaise Claude bought 9,746 shares of Sarepta Therapeutics, Inc. at $25.18 per share, a transaction worth $245.4K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
9,746
Price
$25.18
Total value
$245.4K
InsiderNicaise Claude
RoleDirector
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateMarch 12, 2025
Filing dateMarch 13, 2025
Shares owned after30,303
OwnershipDirect
10b5-1 planNo
AmendedNo